BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 27537911)

  • 1. Identification of an Essential Region for Translocation of Clostridium difficile Toxin B.
    Chen S; Wang H; Gu H; Sun C; Li S; Feng H; Wang J
    Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27537911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A segment of 97 amino acids within the translocation domain of Clostridium difficile toxin B is essential for toxicity.
    Zhang Y; Shi L; Li S; Yang Z; Standley C; Yang Z; ZhuGe R; Savidge T; Wang X; Feng H
    PLoS One; 2013; 8(3):e58634. PubMed ID: 23484044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.
    Li S; Shi L; Yang Z; Zhang Y; Perez-Cordon G; Huang T; Ramsey J; Oezguen N; Savidge TC; Feng H
    Infect Immun; 2015 Feb; 83(2):502-13. PubMed ID: 25404023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B.
    Genisyuerek S; Papatheodorou P; Guttenberg G; Schubert R; Benz R; Aktories K
    Mol Microbiol; 2011 Mar; 79(6):1643-54. PubMed ID: 21231971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.
    Zhang Y; Hamza T; Gao S; Feng H
    Biochem Biophys Res Commun; 2015 Apr; 459(2):259-263. PubMed ID: 25725153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic Toxin-Derived Peptides Destabilize and Inactivate
    Larabee JL; Bland SJ; Hunt JJ; Ballard JD
    mBio; 2017 May; 8(3):. PubMed ID: 28512094
    [No Abstract]   [Full Text] [Related]  

  • 7. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile toxins A and B: Receptors, pores, and translocation into cells.
    Orrell KE; Zhang Z; Sugiman-Marangos SN; Melnyk RA
    Crit Rev Biochem Mol Biol; 2017 Aug; 52(4):461-473. PubMed ID: 28545305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.
    Yuan P; Zhang H; Cai C; Zhu S; Zhou Y; Yang X; He R; Li C; Guo S; Li S; Huang T; Perez-Cordon G; Feng H; Wei W
    Cell Res; 2015 Feb; 25(2):157-68. PubMed ID: 25547119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate.
    Egerer M; Giesemann T; Herrmann C; Aktories K
    J Biol Chem; 2009 Feb; 284(6):3389-95. PubMed ID: 19047051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells.
    Rupnik M; Pabst S; Rupnik M; von Eichel-Streiber C; Urlaub H; Söling HD
    Microbiology (Reading); 2005 Jan; 151(Pt 1):199-208. PubMed ID: 15632438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective mutations within the translocation domain of Clostridium difficile toxin B impair disease pathogenesis.
    Hamza T; Zhang Z; Melnyk RA; Feng H
    Pathog Dis; 2016 Feb; 74(1):ftv098. PubMed ID: 26507679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.
    Li S; Shi L; Yang Z; Feng H
    Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile.
    Zhang BZ; Cai J; Yu B; Hua Y; Lau CC; Kao RY; Sze KH; Yuen KY; Huang JD
    BMC Infect Dis; 2016 Oct; 16(1):596. PubMed ID: 27770789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
    D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
    BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for recognition of frizzled proteins by
    Chen P; Tao L; Wang T; Zhang J; He A; Lam KH; Liu Z; He X; Perry K; Dong M; Jin R
    Science; 2018 May; 360(6389):664-669. PubMed ID: 29748286
    [No Abstract]   [Full Text] [Related]  

  • 17. Clostridium difficile Toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism.
    Chumbler NM; Farrow MA; Lapierre LA; Franklin JL; Haslam DB; Goldenring JR; Lacy DB
    PLoS Pathog; 2012; 8(12):e1003072. PubMed ID: 23236283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin A.
    Schoentaube J; Olling A; Tatge H; Just I; Gerhard R
    Cell Microbiol; 2009 Dec; 11(12):1816-26. PubMed ID: 19709124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
    Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
    Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile.
    Hartley-Tassell LE; Awad MM; Seib KL; Scarselli M; Savino S; Tiralongo J; Lyras D; Day CJ; Jennings MP
    Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30530621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.